Detections
Analytics

CVE-2025-61940

high

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

References

https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01

https://www.hipaajournal.com/mirion-medical-ec2-software-nmis-biodose-vulnerabilities-2025/

https://www.databreachtoday.com/cisa-warns-severe-flaws-in-nuclear-med-tracking-software-a-30189

Details

Source: Mitre, NVD

Published: 2025-12-02

Updated: 2026-01-02

Risk Information

CVSS v2

Base Score: 9

Vector: CVSS2#AV:N/AC:L/Au:S/C:C/I:C/A:C

Severity: High

CVSS v3

Base Score: 8.8

Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Severity: High

CVSS v4

Base Score: 8.7

Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N

Severity: High

EPSS

EPSS: 0.00065